This comprehensive SWOT profile of Fresenius Kabi Oncology Limited provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company's ... TransWorldNews, 3 weeks ago
Fresenius Kabi drops after setting indicative price for delisting - India Infoline, 1 month ago
Fresenius Kabi delisting offer - Money Control, 1 month ago
(3) images for "fresenius kabi oncology"
0 Comments, Be the first to comment Moneylife Digital Team | 18/04/2013 03:39 PM | The world-class oncology drug manufacturer has decided to delist its shares from the bourses at Rs130 instead of complying with SEBI's mandate of 25% public float.Money Life, 1 month ago
Fresenius Kabi has learned an important lesson: if you're going to develop your own robot, never talk about your secret plans in public. Health Robotics issued a stern warning to companies in its support channel who think about evolving into ...TMC Net, 1 month ago Health Robotics Expands IV Bag Support To Hospira's LifeCareTM; Cuts Fresenius Support After RIVA Decision TheStreet.com, 1 month ago Local Government Announces Cost and Safety Benefits of First i.v.STATION Robot at University Hospital in African Continent Scottrade, 1 week ago
SES says Fresenius violated Sebi guidelines on OFS sales unless it has valid and acceptable reasons Aman Malik New Delhi: Stakeholders Empowerment Services (SES), a shareholder-advisory firm, has recommended that stockholders of drug maker ...Livemint.com, 3 weeks ago
Health Robotics Reports 28 New Agreements in 1Q2013, Including 18 Contracts in the United States of America
Health Robotics reported 28 new contracts in 1Q2013, including 12 new Robots [versus 6 Robots in 1Q2012; 8 for Oncology and 4 for non-hazardous IVs] and 16 new i.v.SOFT workflow software agreements [versus 11 i.v.SOFT contracts in 1Q2012]. After a ...Asian Hospital & Healthcare Management, 4 weeks ago
The open offer to buy back the shares of Hindustan Unilever (HUL) seems to have set tongues wagging, as suggested by the renewed clamour for MNC stocks. The share prices of many MNCs have moved up sharply in anticipation of more open offers. While ...Economic Times, 1 week ago
APP Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new company profile report
APP Pharmaceuticals, Inc (APP) is a pharmaceutical company, which specializes in developing, manufacturing and marketing injectable pharmaceutical products. It focuses on injectable critical care, anti-infective and oncology markets. APP flagship ...TransWorldNews, 1 week ago Top 50 pharma cos report 22% growth in sales in 9 months of 2012-13: Pharmabiz study PharmaBiz, 2 months ago
Tater told CNBC-TV18, "We were actually looking Oracle Financial Services Software might actually go for delisting way back six months down the line, but what happened when these kind of things actually started coming in likes of AstraZeneca and we ...Moneycontrol.com, 1 week ago
MUMBAI: India's capital market regulator the (Sebi) is adopting a tough stance against some multinational companies for allegedly taking liberties with the regulator's rules that make it mandatory for promoters of listed companies to increase the ...Economic Times, 3 weeks ago
6:00 PM Mumbai CRISIL fourth quarter net declined 15% and Essar Ports net swung to profit. Government controlled HMT soared on speculation of capital injection. IndusInd Bank fourth quarter net climbed 37.6% and MRF second quarter net jumped 40%.123Jump, 1 month ago
on your WebpageAdd Widget >Get your members hooked!